Contributors

Wednesday, February 6, 2013

Dapoxetine and PDE5i in PE

Dapoxetine and PDE5i in PE - Dapoxitine only approved in some countries including Korea, Rapid acting & short half-life SSRI with a pharmacokinetic profile suggesting a role as on-demand treatment for PE.
Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)